Moderna’s COVID-19 Vaccine Rated ‘Highly Effective,’ Clearing Final Hurdle for FDA Emergency Use Authorization
on December 17, 2020
29 Comments
The second promising coronavirus vaccine from Moderna has tested 94 percent effective at preventing symptomatic illness and appears to prevent the spread of the virus as well. It looks like all systems are go for FDA "emergency use" approval by the end of the week.
The high efficacy of the Moderna vaccine was noted after two doses given 28 days apart. This is about the same level of effectiveness as the Pfizer vaccine.





